Sort by
Refine Your Search
-
. This role offers a rare opportunity to contribute to cancer interception science at the frontier of personalised prevention, with strong translational potential. We are seeking a talented and motivated
-
to understanding the origins and progression of paediatric brain tumours and developing new therapeutic strategies. The lab combines genetic engineering, molecular biology, and translational research to investigate
-
A position exists for a Post Doctoral Research Associate in the Department of Applied Mathematics and Theoretical Physics, funded by the High Energy Physics group's STFC Consolidated grant. The research undertaken includes the interpretation of collider data and theory support for LHC...
-
Fixed-term: The funds for this post are available for 36 months in the first instance. We are looking for a Post-Doctoral Research Associate (PDRA), with a PhD in Physics, Materials Science or
-
close to completing, an undergraduate or Masters' degree in an appropriate field (e.g. microbiology, biomedical science, biochemistry, molecular biology) and/or have relevant experience at an equivalent
-
bioinformatics/computer science will be essential. Prior experience with connectomics data is highly desirable. Our group has developed an international reputation in this area and our tools have now been used in
-
at the Yusuf Hamied Department of Chemistry, University of Cambridge to work on the BBSRC grant "A Platform for Identifying GlycoRNA and Identifying Biases in RNA Pulldown". The role is to develop methods
-
efficient DNA repair, and particularly, how this impacts mutagenesis. The postholder will assist with a variety of molecular biology experiments to identify and characterise DNA damage response mechanisms
-
modelling of the C. elegans neural network. The lab also uses Two Electrode Voltage Clamp (TEVC) electrophysiology and molecular biology techniques to characterise receptors. There are a broad range of
-
University Department of Psychiatry, clinical institutions such as Cambridgeshire and Peterborough NHS Foundation Trust, and with a secondment to industry (Akrivia Health) to advance science and develop common